Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.55 |
| ▸ | TP53 | P04637 | 1/20 | 0.55 |
| ▸ | CA1 | P00915 | 3/20 | 0.50 |
| ▸ | CA2 | P00918 | 3/20 | 0.50 |
| ▸ | SRD5A2 | P31213 | 3/20 | 0.48 |
| ▸ | CA12 | O43570 | 1/20 | 0.46 |
| ▸ | CA3 | P07451 | 1/20 | 0.46 |
| ▸ | TYR | P14679 | 1/20 | 0.46 |
| ▸ | DRD1 | P21728 | 1/20 | 0.46 |
| ▸ | CA4 | P22748 | 1/20 | 0.46 |
| ▸ | CA6 | P23280 | 1/20 | 0.46 |
| ▸ | CA5A | P35218 | 1/20 | 0.46 |
| ▸ | CA7 | P43166 | 1/20 | 0.46 |
| ▸ | CA9 | Q16790 | 1/20 | 0.46 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.46 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.44 |
| ▸ | TPMT | P51580 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4100299 | 0.84 | TSHR (0.52) | TSHRTP53CA1CA2SRD5A2 | |
| SCHEMBL28104659 | 0.83 | TSHR (0.50) | TSHRTP53CA1CA2SRD5A2 | |
| SCHEMBL3470948 | 0.83 | TSHR (0.50) | TSHRTP53CA1CA2SRD5A2 | |
| SCHEMBL1091172 | 0.83 | CA1 (0.52) | TSHRTP53CA1CA2SRD5A2 | |
| SCHEMBL31718045 | 0.80 | TSHR (0.67) | TSHRTP53CA1CA2SRD5A2 | |
| SCHEMBL211951 | 0.80 | ALDH1A1 (0.41) | ALDH1A1CES2CES1 | |
| SCHEMBL28132197 | 0.79 | TSHR (0.46) | TSHRTP53CA1CA2SRD5A2 | |
| Terephthalic Acid SCHEMBL29375683 | 0.78 | TSHR (0.63) | TSHRTP53CA1CA2SRD5A2 | |
| SCHEMBL128618 | 0.78 | TSHR (0.63) | TSHRTP53CA1CA2SRD5A2 | |
| SCHEMBL16898290 | 0.77 | TRPV6 (0.64) | TSHRTP53CA1CA2SRD5A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20010020104-A1 | Process for preparing substituted benzyl compounds and toluene derivatives | CLARIANT GMBH | 2001-09-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010020104-A1 | Process for preparing substituted benzyl compounds and toluene derivatives | NISCH, TBCB, NBAS | TSHR 3294/4885TP53 3645/4885CA1 4350/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.